These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21474828)

  • 21. Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice.
    Out R; Hoekstra M; Hildebrand RB; Kruit JK; Meurs I; Li Z; Kuipers F; Van Berkel TJ; Van Eck M
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2295-300. PubMed ID: 16857950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice.
    Babaev VR; Patel MB; Semenkovich CF; Fazio S; Linton MF
    J Biol Chem; 2000 Aug; 275(34):26293-9. PubMed ID: 10858435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrophage NCOR1 protects from atherosclerosis by repressing a pro-atherogenic PPARγ signature.
    Oppi S; Nusser-Stein S; Blyszczuk P; Wang X; Jomard A; Marzolla V; Yang K; Velagapudi S; Ward LJ; Yuan XM; Geiger MA; Guillaumon AT; Othman A; Hornemann T; Rancic Z; Ryu D; Oosterveer MH; Osto E; Lüscher TF; Stein S
    Eur Heart J; 2020 Mar; 41(9):995-1005. PubMed ID: 31529020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages through a peroxisome proliferator-activated receptor gamma-dependent pathway.
    Avallone R; Demers A; Rodrigue-Way A; Bujold K; Harb D; Anghel S; Wahli W; Marleau S; Ong H; Tremblay A
    Mol Endocrinol; 2006 Dec; 20(12):3165-78. PubMed ID: 16959872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloid Cell PKM2 Deletion Enhances Efferocytosis and Reduces Atherosclerosis.
    Doddapattar P; Dev R; Ghatge M; Patel RB; Jain M; Dhanesha N; Lentz SR; Chauhan AK
    Circ Res; 2022 Apr; 130(9):1289-1305. PubMed ID: 35400205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expressions of atherosclerosis-related genes in aorta in young apoE/LDLR double knockout mice].
    Dai XD; Yin M; Jing W; DU HQ; Ye HY; Shang YJ; Zhang L; Zou YY; Qu ZP; Pan J
    Sheng Li Xue Bao; 2008 Feb; 60(1):43-50. PubMed ID: 18288357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of
    Babaev VR; Huang J; Ding L; Zhang Y; May JM; Linton MF
    Front Immunol; 2018; 9():215. PubMed ID: 29487597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukocyte Overexpression of Intracellular NAMPT Attenuates Atherosclerosis by Regulating PPARγ-Dependent Monocyte Differentiation and Function.
    Bermudez B; Dahl TB; Medina I; Groeneweg M; Holm S; Montserrat-de la Paz S; Rousch M; Otten J; Herias V; Varela LM; Ranheim T; Yndestad A; Ortega-Gomez A; Abia R; Nagy L; Aukrust P; Muriana FJG; Halvorsen B; Biessen EAL
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1157-1167. PubMed ID: 28408371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pro- and antiatherogenic effects of a dominant-negative P465L mutation of peroxisome proliferator-activated receptor-γ in apolipoprotein E-Null mice.
    Pendse AA; Johnson LA; Kim HS; McNair M; Nipp CT; Wilhelm C; Maeda N
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1436-44. PubMed ID: 22539598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The absence of macrophage Nrf2 promotes early atherogenesis.
    Ruotsalainen AK; Inkala M; Partanen ME; Lappalainen JP; Kansanen E; Mäkinen PI; Heinonen SE; Laitinen HM; Heikkilä J; Vatanen T; Hörkkö S; Yamamoto M; Ylä-Herttuala S; Jauhiainen M; Levonen AL
    Cardiovasc Res; 2013 Apr; 98(1):107-15. PubMed ID: 23341579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor gamma-dependent pathway.
    Barlic J; Zhang Y; Foley JF; Murphy PM
    Circulation; 2006 Aug; 114(8):807-19. PubMed ID: 16908772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mediator 1 Is Atherosclerosis Protective by Regulating Macrophage Polarization.
    Bai L; Li Z; Li Q; Guan H; Zhao S; Liu R; Wang R; Zhang J; Jia Y; Fan J; Wang N; Reddy JK; Shyy JY; Liu E
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1470-1481. PubMed ID: 28642237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of soluble epoxide hydrolase alleviated atherosclerosis by reducing monocyte infiltration in Ldlr(-/-) mice.
    Li D; Liu Y; Zhang X; Lv H; Pang W; Sun X; Gan LM; Hammock BD; Ai D; Zhu Y
    J Mol Cell Cardiol; 2016 Sep; 98():128-37. PubMed ID: 27496380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage adipose triglyceride lipase deficiency attenuates atherosclerotic lesion development in low-density lipoprotein receptor knockout mice.
    Lammers B; Chandak PG; Aflaki E; Van Puijvelde GH; Radovic B; Hildebrand RB; Meurs I; Out R; Kuiper J; Van Berkel TJ; Kolb D; Haemmerle G; Zechner R; Levak-Frank S; Van Eck M; Kratky D
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):67-73. PubMed ID: 21030715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepcidin Deficiency Protects Against Atherosclerosis.
    Malhotra R; Wunderer F; Barnes HJ; Bagchi A; Buswell MD; O'Rourke CD; Slocum CL; Ledsky CD; Peneyra KM; Sigurslid H; Corman B; Johansson KB; Rhee DK; Bloch KD; Bloch DB
    Arterioscler Thromb Vasc Biol; 2019 Feb; 39(2):178-187. PubMed ID: 30587002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice.
    Larmann J; Jurk K; Janssen H; Müller M; Herzog C; Lorenz A; Schmitz M; Nofer JR; Theilmeier G
    PLoS One; 2015; 10(8):e0131854. PubMed ID: 26313756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary cholesterol plays a role in CD36-mediated atherogenesis in LDLR-knockout mice.
    Kennedy DJ; Kuchibhotla SD; Guy E; Park YM; Nimako G; Vanegas D; Morton RE; Febbraio M
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1481-7. PubMed ID: 19608973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, reduces atherosclerosis in female low density lipoprotein receptor deficient mice.
    Chira EC; McMillen TS; Wang S; Haw A; O'Brien KD; Wight TN; Chait A
    Atherosclerosis; 2007 Nov; 195(1):100-9. PubMed ID: 17214992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibiting DNA Methylation by 5-Aza-2'-deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation.
    Cao Q; Wang X; Jia L; Mondal AK; Diallo A; Hawkins GA; Das SK; Parks JS; Yu L; Shi H; Shi H; Xue B
    Endocrinology; 2014 Dec; 155(12):4925-38. PubMed ID: 25251587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discoidin domain receptor 1 on bone marrow-derived cells promotes macrophage accumulation during atherogenesis.
    Franco C; Britto K; Wong E; Hou G; Zhu SN; Chen M; Cybulsky MI; Bendeck MP
    Circ Res; 2009 Nov; 105(11):1141-8. PubMed ID: 19834008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.